Luminex Corp. (LMNX) – FDA
-
Luminex (LMNX) Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
-
Luminex Corp. (LMNX) Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LMNX Stock Lookup